DLD and Hepatic fibrosis: At the same time, the expression of P62, DLD, PACS‐2, MFN2, lipoic acid‐modified proteins, and DLAT oligomerized proteins significantly increased, suggesting that DATs exert therapeutic effects on liver fibrosis by inhibiting lipophagy and inducing cuproptosis (Figure 9b and Figure S8f, Supporting Information).